Co-occurring mental and substance abuse disorders: A review on the potential predictors and clinical outcomes

@article{Najt2011CooccurringMA,
  title={Co-occurring mental and substance abuse disorders: A review on the potential predictors and clinical outcomes},
  author={Pablo Najt and Paolo Fusar-Poli and Paolo Brambilla},
  journal={Psychiatry Research},
  year={2011},
  volume={186},
  pages={159-164},
  url={https://api.semanticscholar.org/CorpusID:1030276}
}

A Systematic Review and Meta-Analysis of Dual Diagnosis Patient Profile in the Clinical Setting

High heterogeneity among the studies was found and persisted in the subgroup analysis and risk of bias assessment in the subgroup analysis of the proportion of dual diagnosis patients in the clinical setting.

Comparison of demographic characteristics and psychiatric comorbidity among methamphetamine-, heroin- and methamphetamine-heroin co- dependent males in Hunan, China

There were substantial differences in epidemiological characteristics and comorbidity among MD, HD and M/HD groups, which highlights the urgent need to develop treatment services and policies for drug-specific users in China.

Marijuana Use and Well-Being in University Students

Marijuana is the most commonly used illicit substance world-wide. Marijuana use is especially prevalent among college and university students and has been associated with both positive and negative…

Exploring Mental Health Distress as a Mediator of Interoceptive Awareness and Alcohol Use Severity: A Test of Alternative Models

This study examined relationships among interoceptive awareness (the ability to detect and understand internal bodily sensations), alcohol use severity, and mental health symptoms using…

Telepsychiatry in addiction treatment: Evaluating India’s telemedicine guidelines

Given India’s high substance uses prevalence, rural healthcare disparities, and a huge substance use disorder treatment gap, telepsychiatry offers a path to improve treatment access and thereby, reducing stigma and improve treatment outcomes, it is severely limiting addiction treatment.

Associations between psychedelic use and adverse outcomes in substance use disorders: a real-world EHR-based cohort study

In this large national cohort, psychedelic use, particularly when combined with anesthetic and outpatient care, was associated with reduced adverse health outcomes among people with SUD and these findings support further investigation into psychedelic-based interventions within integrated treatment frameworks.

Co‑occurring mental and substance use disorders among residents of Drug Addiction Rehabilitation Centers (DARCs) in Japan: Characterizing dual‑diagnosis profiles

Individuals with dual diagnoses were more likely to be female, have histories of incarceration, and have prior treatment experiences, highlighting the need for tailored support in recovery programs.

Psychosocial interventions for people with comorbid substance use disorders in people with severe mental health conditions in low- and middle-income countries: scoping review

There is a clear need to design and test feasible, acceptable, and effective interventions to address both severe MHCs and substance use when they co-occur, and there have been few initiatives to design and test psychosocial interventions.

Anti-drug vaccines as a harm reduction strategy: potential, limitations, and translational challenges

When integrated with behavioral, pharmacological, and psychosocial interventions, anti-drug immunotherapies may enhance the effectiveness of existing harm reduction strategies, and their potential lies not in replacing current approaches but in reinforcing them.
...

Prevalence and risk factors for posttraumatic stress disorder among chemically dependent adolescents.

The lifetime prevalence of PTSD among these chemically dependent adolescents is five times that reported for a community sample of adolescents, providing new understanding of the etiologic connection between PTSD and chemical dependence and has implications for their treatment.

Alcoholism in manic-depressive (bipolar) illness: familial illness, course of illness, and the primary-secondary distinction.

The study supports the idea that not all alcoholism is primary with a corresponding familial diathesis, and that alcoholism associated with bipolar disorder is often a secondary complication.

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

The prevalence of psychiatric disorders is greater than previously thought to be the case, and morbidity is more highly concentrated than previously recognized in roughly one sixth of the population who have a history of three or more comorbid disorders.

Diagnostic and Statistical Manual of Mental Disorders

Given the recent attention to movement abnormalities in psychosis spectrum disorders (e.g

Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs.

There is a need to expand the evidence base on comorbidity, particularly in low-income countries, and policies that reduce the use of substances are likely to reduce the prevalence of mental disorders.

Impact of comorbid psychiatric disorders on the outcome of substance abusers: a six year prospective follow-up in two Norwegian counties

Multivariate analysis indicated that both psychiatric disorders (major depression) and substance use factors (early onset of a substance use disorder) were independent predictors of relapse.

Factors associated with temporal priority in comorbid bipolar I disorder and alcohol use disorders: Results from the national epidemiologic survey on alcohol and related conditions.

Temporal priority in comorbid bipolar I Disorder and AUD is associated with several significant between-group differences in features of bipolar I disorder and AUD severity, treatment utilization, other comor bidities, and family history.

Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants.

The validity of a primary/secondary substance use disorder (SUD) distinction was evaluated in the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder and it was found that variations in the age of onset of the non-SUD are linked to course characteristics.